Search
HomeBusiness

Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm

NY Times
NY Times

The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefits and serious safety risks.  » mehr lesen

NY Times
NY Times
Previous article
How Companies Handled Texas’ Abortion Restrictions
Next article
Politico published the Roe v. Wade draft opinion after an ‘extensive review process.’

Similar Articles

Tottenham Hotspur Owner Joe Lewis Is Charged in U.S. With Insider Trading

Business NY Times -
Federal prosecutors in Manhattan accused the British billionaire of illegally funneling nonpublic information to associates to trade on.  » mehr lesen

How Travelers Can Navigate Flight Cancellations and Delays

Business NY Times -
Advocating for yourself after an airline delay or cancellation can be challenging and confusing. Here’s how to best achieve the result you want —...

Most Popular

Copyright @ Home Business Factor | Created with ♥ in North Carolina